Learn More
Medchemexpress LLC Farnesyl pyrophosphate (ammonium) | 116057-57-9 | 95.4% | 433.42 | 10 MG

Supplier: Medchemexpress LLC HY113037C10MG
Farnesyl pyrophosphate (Farnesyl diphosphate) ammonium is a metabolic intermediate in the mevalonate (MVA) pathway and acts as a TRP channel (TRPM2) agonist, triggering Ca2+ influx and cell death. This compound is a critical branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. It is utilized in research concerning cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.
- Metabolic intermediate in the mevalonate (MVA) pathway.
- TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death.
- Key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis.
- Used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.